These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14998670)

  • 1. In vitro characterization of liposomes and Optison by acoustic scattering at 3.5 MHz.
    Coussios CC; Holland CK; Jakubowska L; Huang SL; MacDonald RC; Nagaraj A; McPherson DD
    Ultrasound Med Biol; 2004 Feb; 30(2):181-90. PubMed ID: 14998670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Destruction thresholds of echogenic liposomes with clinical diagnostic ultrasound.
    Smith DA; Porter TM; Martinez J; Huang S; MacDonald RC; McPherson DD; Holland CK
    Ultrasound Med Biol; 2007 May; 33(5):797-809. PubMed ID: 17412486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acoustic techniques for assessing the Optison destruction threshold.
    Porter TM; Smith DA; Holland CK
    J Ultrasound Med; 2006 Dec; 25(12):1519-29. PubMed ID: 17121946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced voiding urosonography: in vitro evaluation of a second-generation ultrasound contrast agent for in vivo optimization.
    Back SJ; Edgar JC; Canning DA; Darge K
    Pediatr Radiol; 2015 Sep; 45(10):1496-505. PubMed ID: 25930084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of echogenic liposome as an ultrasound contrast agent: size-dependency and stabilizing effect of cholesterol on the echogenicity of gas-entrapping liposome.
    Kimura A; Sakai A; Tsukishiro S; Beppu S; Fujiwara H
    Chem Pharm Bull (Tokyo); 1998 Oct; 46(10):1493-6. PubMed ID: 9810688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental acoustic characterization of an endoskeletal antibubble contrast agent: First results.
    Panfilova A; Chen P; van Sloun RJG; Wijkstra H; Postema M; Poortinga AT; Mischi M
    Med Phys; 2021 Nov; 48(11):6765-6780. PubMed ID: 34580883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of fluorous lipid-based nanobubbles for efficiently containing perfluoropropane.
    Oda Y; Suzuki R; Mori T; Takahashi H; Natsugari H; Omata D; Unga J; Uruga H; Sugii M; Kawakami S; Higuchi Y; Yamashita F; Hashida M; Maruyama K
    Int J Pharm; 2015 Jun; 487(1-2):64-71. PubMed ID: 25841568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acoustic characterization of echogenic liposomes: frequency-dependent attenuation and backscatter.
    Kopechek JA; Haworth KJ; Raymond JL; Douglas Mast T; Perrin SR; Klegerman ME; Huang S; Porter TM; McPherson DD; Holland CK
    J Acoust Soc Am; 2011 Nov; 130(5):3472-81. PubMed ID: 22088022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inertial cavitation dose and hemolysis produced in vitro with or without Optison.
    Chen WS; Brayman AA; Matula TJ; Crum LA
    Ultrasound Med Biol; 2003 May; 29(5):725-37. PubMed ID: 12754072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadband attenuation measurements of phospholipid-shelled ultrasound contrast agents.
    Raymond JL; Haworth KJ; Bader KB; Radhakrishnan K; Griffin JK; Huang SL; McPherson DD; Holland CK
    Ultrasound Med Biol; 2014 Feb; 40(2):410-21. PubMed ID: 24262056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inertial cavitation dose produced in ex vivo rabbit ear arteries with Optison by 1-MHz pulsed ultrasound.
    Tu J; Matula TJ; Brayman AA; Crum LA
    Ultrasound Med Biol; 2006 Feb; 32(2):281-8. PubMed ID: 16464673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Newtonian rheological model for the interface of microbubble contrast agents.
    Chatterjee D; Sarkar K
    Ultrasound Med Biol; 2003 Dec; 29(12):1749-57. PubMed ID: 14698342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of ultrasound pulses combined with Definity for targeted blood-brain barrier disruption: a feasibility study.
    McDannold N; Vykhodtseva N; Hynynen K
    Ultrasound Med Biol; 2007 Apr; 33(4):584-90. PubMed ID: 17337109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-Stent B-Mode Ultrasound and Passive Cavitation Imaging.
    Haworth KJ; Raymond JL; Radhakrishnan K; Moody MR; Huang SL; Peng T; Shekhar H; Klegerman ME; Kim H; McPherson DD; Holland CK
    Ultrasound Med Biol; 2016 Feb; 42(2):518-27. PubMed ID: 26547633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors].
    Jung EM; Clevert DA; Rupp N
    Rofo; 2003 Oct; 175(10):1403-12. PubMed ID: 14556110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental study of the effects of Optison concentration on sonoporation in vitro.
    Ward M; Wu J; Chiu JF
    Ultrasound Med Biol; 2000 Sep; 26(7):1169-75. PubMed ID: 11053752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of liposomes to sonoporation.
    Wu J; Chen D; Pepe J; Himberg BE; Ricń M
    Ultrasound Med Biol; 2006 Mar; 32(3):429-37. PubMed ID: 16530102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the hemolytic potential of Optison and Albunex in whole human blood in vitro: acoustic pressure, ultrasound frequency, donor and passive cavitation detection considerations.
    Miller MW; Everbach EC; Cox C; Knapp RR; Brayman AA; Sherman TA
    Ultrasound Med Biol; 2001 May; 27(5):709-21. PubMed ID: 11397535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of a high-order Bessel beam with a submerged spherical ultrasound contrast agent shell - Scattering theory.
    Mitri FG
    Ultrasonics; 2010 Mar; 50(3):387-96. PubMed ID: 19833370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the fragmentation thresholds and inertial cavitation doses of different ultrasound contrast agents.
    Chen WS; Matula TJ; Brayman AA; Crum LA
    J Acoust Soc Am; 2003 Jan; 113(1):643-51. PubMed ID: 12558300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.